Clinical Trial

Tyrosine Allergoid Paediatric and Adult Study

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 30, 2026 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.
Summary
The primary objective of this 5-year study is to demonstrate non-inferiority of children compared to adults by exploring long-term effectiveness after treatment with TA Bäume (trees) and TA Gräser (grass) following a perennial posology.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2022-01-10; most recent amendment 2026-01-28.
Status change: Recruiting → Active, Not Recruiting 2022-10-05
Trial Details
NCT Number NCT05186025
Lead Sponsor Allergy Therapeutics
Collaborators: Bencard Allergie GmbH
Conditions Allergic Rhinitis Due to Pollen, Allergic Conjunctivitis, Allergic Asthma
Enrollment 320 participants
Start Date 2020-11-06
Primary Completion 2026-06 (estimated)
Study Completion 2026-10 (estimated)
Updated on ClinicalTrials.gov 2026-01-30